Want news about Vijaya Bank to land in your mailbox?

Buy Vijaya Bank; target of Rs 57-58: IndiaInfoline
IndiaInfoline has recommended buy rating on Vijaya Bank with a target of Rs 57-58, in its November 23, 2009 research report.
"On the weekly chart, Vijaya Bank is attempting to break out from a 19-month resistance zone. Since past few weeks, the stock was moving in a range of Rs48-52. On Friday, the stock made an attempt to break out from the top of the above trading range also. Moreover, cluster of moving averages are proving good support to the stock at current levels. We expect the stock to stage a smart rally in the near term. Traders can buy the stock with a strict stop loss of Rs 50 for a target of Rs 57-58," says IndiaInfoline research report.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
|
|
To read the full report click on the attachment.........
Attachments : IndiaInfoline_Vijaya Bank.pdf |
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
Martin Pieters
MD and CEO
Vodafone
See major growth opportunities in rural India: Vodafone
Rakesh Parikh
VP-Finance
Unichem Lab
Domestic formulations to grow significantly ahead: Unichem
Koshi Varghese
Executive VP-Marketing
MRF
Input costs hitting margins, see tyre price hike ahead: MRF
Venkat Jasti
Chief Executive Officer
Suven Life Sciences
See 25% growth in CRAMS biz next year: Suven Life Sciences
-
Most Read
-
Most Viewed
- Raamdeo Agrawal's top sector picks for your portfolio

- Persistent Systems IPO overbid; should you invest?
- 10-15% mkt rise in a month not good for India: Blackstone

- Raaja Kanwar: Taking the unusual path to expand Apollo

- Demerging non-core biz a positive for Unitech: Tulsian

- Anu Jain's top 5 picks for trade today

- See Nifty heading towards 5400-5500 in near-term: Edelweiss

- Ashwani Gujral's top five picks for today's trade

- Persistent IPO clocks highest bid in 26 mths at 93 times
- Unitech can touch Rs 100: Gujral

- Jewellers head to Dalal Street
Source: Business Line
- Nissan to build plug-in car in UK
Source: ft.com
- Mystery Shopper: Kurtis and cattle in Mumbai
Source: ft.com
- Shree Ganesh plans to raise Rs 375 cr via IPO
Source: Business Line


















